162 related articles for article (PubMed ID: 16033271)
1. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
Durgam GG; Virag T; Walker MD; Tsukahara R; Yasuda S; Liliom K; van Meeteren LA; Moolenaar WH; Wilke N; Siess W; Tigyi G; Miller DD
J Med Chem; 2005 Jul; 48(15):4919-30. PubMed ID: 16033271
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
Durgam GG; Tsukahara R; Makarova N; Walker MD; Fujiwara Y; Pigg KR; Baker DL; Sardar VM; Parrill AL; Tigyi G; Miller DD
Bioorg Med Chem Lett; 2006 Feb; 16(3):633-40. PubMed ID: 16263282
[TBL] [Abstract][Full Text] [Related]
3. Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.
Gududuru V; Zeng K; Tsukahara R; Makarova N; Fujiwara Y; Pigg KR; Baker DL; Tigyi G; Miller DD
Bioorg Med Chem Lett; 2006 Jan; 16(2):451-6. PubMed ID: 16290140
[TBL] [Abstract][Full Text] [Related]
4. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
5. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
Xu Y; Jiang G; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
J Med Chem; 2006 Aug; 49(17):5309-15. PubMed ID: 16913720
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
[TBL] [Abstract][Full Text] [Related]
7. Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
Heasley BH; Jarosz R; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2004 Jun; 14(11):2735-40. PubMed ID: 15125924
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
9. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood.
Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J
J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
[TBL] [Abstract][Full Text] [Related]
12. alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitors.
Cui P; McCalmont WF; Tomsig JL; Lynch KR; Macdonald TL
Bioorg Med Chem; 2008 Mar; 16(5):2212-25. PubMed ID: 18082408
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid.
Liu XW; Sok DE; Yook HS; Sohn CB; Chung YJ; Kim MR
J Agric Food Chem; 2007 Oct; 55(21):8717-22. PubMed ID: 17887800
[TBL] [Abstract][Full Text] [Related]
14. A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.
Heasley BH; Jarosz R; Carter KM; Van SJ; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2004 Aug; 14(15):4069-74. PubMed ID: 15225728
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
[TBL] [Abstract][Full Text] [Related]
16. A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
Terauchi M; Abe H; Tovey SC; Dedos SG; Taylor CW; Paul M; Trusselle M; Potter BV; Matsuda A; Shuto S
J Med Chem; 2006 Mar; 49(6):1900-9. PubMed ID: 16539376
[TBL] [Abstract][Full Text] [Related]
17. Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.
Virag T; Elrod DB; Liliom K; Sardar VM; Parrill AL; Yokoyama K; Durgam G; Deng W; Miller DD; Tigyi G
Mol Pharmacol; 2003 May; 63(5):1032-42. PubMed ID: 12695531
[TBL] [Abstract][Full Text] [Related]
18. Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics.
Hopper DW; Ragan SP; Hooks SB; Lynch KR; Macdonald TL
J Med Chem; 1999 Mar; 42(6):963-70. PubMed ID: 10090779
[TBL] [Abstract][Full Text] [Related]
19. Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
Liliom K; Tsukahara T; Tsukahara R; Zelman-Femiak M; Swiezewska E; Tigyi G
Biochim Biophys Acta; 2006 Dec; 1761(12):1506-14. PubMed ID: 17092771
[TBL] [Abstract][Full Text] [Related]
20. Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cells.
Moughal NA; Waters CM; Valentine WJ; Connell M; Richardson JC; Tigyi G; Pyne S; Pyne NJ
J Neurochem; 2006 Sep; 98(6):1920-9. PubMed ID: 16945108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
